ASCO: Roche, Jazz's Zepzelca small cell lung cancer win leaves room for improvement

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. But the pair’s success leaves room for improvement for future contenders.

May 22, 2025 - 22:50
 0
ASCO: Roche, Jazz's Zepzelca small cell lung cancer win leaves room for improvement
Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. But the pair’s success leaves room for improvement for future contenders.